Literature DB >> 23152519

The hemagglutinin protein of highly pathogenic H5N1 influenza viruses overcomes an early block in the replication cycle to promote productive replication in macrophages.

Troy D Cline1, Erik A Karlsson, Bradley J Seufzer, Stacey Schultz-Cherry.   

Abstract

Macrophages are known to be one of the first lines of defense against influenza virus infection. However, they may also contribute to severe disease caused by the highly pathogenic avian (HPAI) H5N1 influenza viruses. One reason for this may be the ability of certain influenza virus strains to productively replicate in macrophages. However, studies investigating the productive replication of influenza viruses in macrophages have been contradictory, and the results may depend on both the type of macrophages used and the specific viral strain. In this work, we investigated the ability of H1 to H16 viruses to productively replicate in primary murine alveolar macrophages and RAW264.7 macrophages. We show that only a subset of HPAI H5N1 viruses, those that cause high morbidity and mortality in mammals, can productively replicate in macrophages, as measured by the release of newly synthesized virus particles into the cell supernatant. Mechanistically, we found that these H5 strains can overcome a block early in the viral life cycle leading to efficient nuclear entry, viral transcription, translation, and ultimately replication. Studies with reassortant viruses demonstrated that expression of the hemagglutinin gene from an H5N1 virus rescued replication of H1N1 influenza virus in macrophages. This study is the first to characterize H5N1 influenza viruses as the only subtype of influenza virus capable of productive replication in macrophages and establishes the viral gene that is required for this characteristic. The ability to productively replicate in macrophages is unique to H5N1 influenza viruses and may contribute to their increased pathogenesis.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23152519      PMCID: PMC3554171          DOI: 10.1128/JVI.02682-12

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  37 in total

1.  Critical role of airway macrophages in modulating disease severity during influenza virus infection of mice.

Authors:  Michelle D Tate; Danielle L Pickett; Nico van Rooijen; Andrew G Brooks; Patrick C Reading
Journal:  J Virol       Date:  2010-05-26       Impact factor: 5.103

2.  Strand-specific real-time RT-PCR for distinguishing influenza vRNA, cRNA, and mRNA.

Authors:  Eiryo Kawakami; Tokiko Watanabe; Ken Fujii; Hideo Goto; Shinji Watanabe; Takeshi Noda; Yoshihiro Kawaoka
Journal:  J Virol Methods       Date:  2010-12-24       Impact factor: 2.014

3.  Increased pathogenicity of a reassortant 2009 pandemic H1N1 influenza virus containing an H5N1 hemagglutinin.

Authors:  Troy D Cline; Erik A Karlsson; Pamela Freiden; Bradley J Seufzer; Jerold E Rehg; Richard J Webby; Stacey Schultz-Cherry
Journal:  J Virol       Date:  2011-09-14       Impact factor: 5.103

4.  Cytokine production by primary human macrophages infected with highly pathogenic H5N1 or pandemic H1N1 2009 influenza viruses.

Authors:  Saori Sakabe; Kiyoko Iwatsuki-Horimoto; Ryo Takano; Chairul A Nidom; Mai Thi Quynh Le; Tokiko Nagamura-Inoue; Taisuke Horimoto; Naohide Yamashita; Yoshihiro Kawaoka
Journal:  J Gen Virol       Date:  2011-03-02       Impact factor: 3.891

Review 5.  Immune responses to influenza virus infection.

Authors:  J H C M Kreijtz; R A M Fouchier; G F Rimmelzwaan
Journal:  Virus Res       Date:  2011-09-22       Impact factor: 3.303

6.  Viral replication and innate host responses in primary human alveolar epithelial cells and alveolar macrophages infected with influenza H5N1 and H1N1 viruses.

Authors:  Wendy C L Yu; Renee W Y Chan; Jieru Wang; Emily A Travanty; John M Nicholls; J S Malik Peiris; Robert J Mason; Michael C W Chan
Journal:  J Virol       Date:  2011-05-04       Impact factor: 5.103

7.  Macrophage receptors for influenza A virus: role of the macrophage galactose-type lectin and mannose receptor in viral entry.

Authors:  Jacqueline P Upham; Danielle Pickett; Tatsuro Irimura; E Margot Anders; Patrick C Reading
Journal:  J Virol       Date:  2010-01-27       Impact factor: 5.103

8.  Transforming growth factor-β: activation by neuraminidase and role in highly pathogenic H5N1 influenza pathogenesis.

Authors:  Christina M Carlson; Elizabeth A Turpin; Lindsey A Moser; Kevin B O'Brien; Troy D Cline; Jeremy C Jones; Terrence M Tumpey; Jacqueline M Katz; Laura A Kelley; Jack Gauldie; Stacey Schultz-Cherry
Journal:  PLoS Pathog       Date:  2010-10-07       Impact factor: 6.823

9.  Highly pathogenic avian influenza virus H5N1 infects alveolar macrophages without virus production or excessive TNF-alpha induction.

Authors:  Debby van Riel; Lonneke M E Leijten; Menno van der Eerden; Henk C Hoogsteden; Leonie A Boven; Bart N Lambrecht; Albert D M E Osterhaus; Thijs Kuiken
Journal:  PLoS Pathog       Date:  2011-06-23       Impact factor: 6.823

10.  Acid stability of the hemagglutinin protein regulates H5N1 influenza virus pathogenicity.

Authors:  Rebecca M DuBois; Hassan Zaraket; Muralidhar Reddivari; Richard J Heath; Stephen W White; Charles J Russell
Journal:  PLoS Pathog       Date:  2011-12-01       Impact factor: 6.823

View more
  23 in total

1.  Infection of Mouse Macrophages by Seasonal Influenza Viruses Can Be Restricted at the Level of Virus Entry and at a Late Stage in the Virus Life Cycle.

Authors:  Sarah L Londrigan; Kirsty R Short; Joel Ma; Leah Gillespie; Steven P Rockman; Andrew G Brooks; Patrick C Reading
Journal:  J Virol       Date:  2015-09-30       Impact factor: 5.103

2.  The macrophage galactose-type lectin can function as an attachment and entry receptor for influenza virus.

Authors:  Wy Ching Ng; Stella Liong; Michelle D Tate; Tatsuro Irimura; Kaori Denda-Nagai; Andrew G Brooks; Sarah L Londrigan; Patrick C Reading
Journal:  J Virol       Date:  2013-11-20       Impact factor: 5.103

3.  Influenza Virus Overcomes Cellular Blocks To Productively Replicate, Impacting Macrophage Function.

Authors:  Shauna A Marvin; Marion Russier; C Theodore Huerta; Charles J Russell; Stacey Schultz-Cherry
Journal:  J Virol       Date:  2017-01-03       Impact factor: 5.103

Review 4.  Roles of Glycans and Non-glycans on the Epithelium and in the Immune System in H1-H18 Influenza A Virus Infections.

Authors:  Nongluk Sriwilaijaroen; Yasuo Suzuki
Journal:  Methods Mol Biol       Date:  2022

Review 5.  The contributions of lung macrophage and monocyte heterogeneity to influenza pathogenesis.

Authors:  Mubing Duan; Margaret L Hibbs; Weisan Chen
Journal:  Immunol Cell Biol       Date:  2016-09-27       Impact factor: 5.126

6.  Human H7N9 and H5N1 influenza viruses differ in induction of cytokines and tissue tropism.

Authors:  Victoria A Meliopoulos; Erik A Karlsson; Lisa Kercher; Troy Cline; Pamela Freiden; Susu Duan; Peter Vogel; Richard J Webby; Yi Guan; Malik Peiris; Paul G Thomas; Stacey Schultz-Cherry
Journal:  J Virol       Date:  2014-09-10       Impact factor: 5.103

Review 7.  Influenza virus replication in macrophages: balancing protection and pathogenesis.

Authors:  Troy D Cline; Donald Beck; Elizabeth Bianchini
Journal:  J Gen Virol       Date:  2017-09-08       Impact factor: 3.891

8.  Importin-α7 is required for enhanced influenza A virus replication in the alveolar epithelium and severe lung damage in mice.

Authors:  Patricia Resa-Infante; René Thieme; Thomas Ernst; Petra C Arck; Harald Ittrich; Rudolph Reimer; Gülsah Gabriel
Journal:  J Virol       Date:  2014-05-14       Impact factor: 5.103

9.  H1N1, but not H3N2, influenza A virus infection protects ferrets from H5N1 encephalitis.

Authors:  Stephanie J Bissel; Guoji Wang; Donald M Carter; Corey J Crevar; Ted M Ross; Clayton A Wiley
Journal:  J Virol       Date:  2013-12-26       Impact factor: 5.103

Review 10.  Hemagglutinin Stability and Its Impact on Influenza A Virus Infectivity, Pathogenicity, and Transmissibility in Avians, Mice, Swine, Seals, Ferrets, and Humans.

Authors:  Charles J Russell
Journal:  Viruses       Date:  2021-04-24       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.